CYClOTHIALIDINE
Compound with spectra: 2 NMR
| SpectraBase Compound ID | 8zxx9oK9GO7 |
|---|---|
| InChI | InChI=1S/C26H35N5O12S/c1-10-17(34)5-18(35)12-8-44-9-15(22(37)28-11(2)25(40)41)30-21(36)14(7-43-26(42)19(10)12)29-23(38)20-16(33)3-4-31(20)24(39)13(27)6-32/h5,11,13-16,20,32-35H,3-4,6-9,27H2,1-2H3,(H,28,37)(H,29,38)(H,30,36)(H,40,41)/t11-,13+,14+,15+,16-,20+/m1/s1 |
| InChIKey | HMHQWJDFNVJCHA-JIZYSWCOSA-N |
| Mol Weight | 641.6 g/mol |
| Molecular Formula | C26H35N5O12S |
| Exact Mass | 641.200293 g/mol |
| Enantiomer InChIKey | HMHQWJDFNVJCHA-VFSVDOBKSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
CYClOTHIALIDINE-E
APETALINE_B
PALIURINE-I
VERRUCAMIDE_A
Propanamide, 2-(dimethylamino)-N-[2-methyl-1-[[3,3a,12,13,14,15,16,16a-octahydro-8-methoxy-13,16-dioxo-14-(phenylmethyl)-5,9-metheno-9H-pyrrolo[3,2-b][1,5,8]oxadiazacyclopentadecin-1(2H)-yl]carbonyl]propyl]-
O-DEMETHYL-MUCRONINE-D
CYCLOMONTANIN_C;CYCLO-(-PHE(1)-PRO-(2)-PRO-(3)-THR-(4)-PHE-(5)-ASN-(6)-HIS-(7)-VAL-(8)-ASN-(9)-)
PALIURINE-E
(3S,4S,5R)-5-Benzyloxy-3-benzyloxycarbonylamino-N-[(1S)-1-(tert-butoxycarbonyl)-3-methylbutyl]-4-methylsulfoxypiperidin-2-one
2-Oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraene-5,8-dione
| Title | Journal or Book | Year |
|---|---|---|
| Cyclothialidine Analogs, Novel DNA Gyrase Inhibitors. | The Journal of Antibiotics | 1997 |
| Cyclothialidine, a novel DNA gyrase inhibitor. II. Isolation, charactenzation and structure elucidation. | The Journal of Antibiotics | 1994 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.